EARLY DIAGNOSIS, PREVENTION AND MANAGEMENT OF RESPIRATORY DISTRESS SYNDROME ACCORDING TO GESTATIONAL AGE IN PRETERM INFANTS

Authors

  • Xayitova Ro‘zaxon Qutbillo qizi Master’s degree student of the Pediatrics and neonatology at Andijan state medical institute.
  • Nuritdinova Gavhar Taipovna Associate professor, PhD, Department of pediatrics and neonatology, Andijan state medical institute.

DOI:

https://doi.org/10.37547/

Keywords:

preterm infants, respiratory distress syndrome, gestational age, surfactant therapy, CPAP, antenatal corticosteroids

Abstract

Respiratory distress syndrome (RDS) remains one of the leading causes of morbidity and mortality in preterm infants, particularly those born at lower gestational ages. The condition primarily results from pulmonary immaturity and surfactant deficiency, leading to alveolar collapse, impaired gas exchange, and progressive respiratory failure. This review aims to analyze current evidence on the early diagnosis, prevention, and management of RDS in preterm neonates, with a specific focus on gestational age–based risk stratification. Evidence indicates that antenatal corticosteroid therapy, early application of continuous positive airway pressure (CPAP), and timely surfactant replacement significantly reduce disease severity and improve neonatal outcomes. Gestational age remains the most critical determinant of RDS risk and therapeutic response. A gestation-tailored, non-invasive, and preventive approach is essential for optimizing survival and reducing complications.

Downloads

Download data is not yet available.

References

1.Kramer BW. The respiratory distress syndrome (RDS) in preterm infants. Intensivmedizin Und Notfallmedizin, 2007.

2.Feijoo Jaramillo MC et al. Antenatal corticotherapy in the prevention of respiratory distress syndrome in preterm neonates. International Journal of Health Sciences, 2024.

3.Dell’Orto V et al. Early nasal CPAP failure prediction in preterm infants. Pediatric Pulmonology, 2021.

4.Rong Z et al. Early versus rescue surfactant administration for RDS. American Journal of Perinatology, 2019.

5.Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome - 2019 update. Neonatology. 2019;115(4):432-450.

6.Polin RA, Carlo WA; Committee on Fetus and Newborn.

Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014; 133(1):156-163.

7.Roberts D, Brown J, Medley N, Dalziel SR.

Antenatal corticosteroids for accelerating fetal lung maturation.

Cochrane Database of Systematic Reviews. 2017;3:CD004454.

8.Urinov R. Innovative approaches to the development of intellectual competence and professional intelligence in future teachers // Теоретические аспекты становления педагогических наук. – 2025. – Т. 4. – №. 17. – С. 112-118.

9.Urinov R. Enhancing the intellectual competence of prospective teachers through the pedagogical implementation of the design thinking approach // Модели и методы в современной науке. – 2025. – Т. 4. – №. 10. – С. 55-60.

Downloads

Published

2026-01-26

How to Cite

EARLY DIAGNOSIS, PREVENTION AND MANAGEMENT OF RESPIRATORY DISTRESS SYNDROME ACCORDING TO GESTATIONAL AGE IN PRETERM INFANTS. (2026). International Bulletin of Medical Sciences and Clinical Research, 6(1), 83-87. https://doi.org/10.37547/

Similar Articles

41-50 of 235

You may also start an advanced similarity search for this article.